Abstract: The present disclosure proposes a lamp with a replaceable power supply module, the lamp including: a lamp body; a power supply module electrically connected to the lamp body to supply power to the lamp body, the power supply module being disposed on the lamp body and provided with a locking portion; and a catch, the catch being provided with a catch body and an elastic member connected to the lamp body, the catch body being rotatably connected to the elastic member, and the locking portion being provided with a locking protrusion, wherein the catch body has a catch recess and a mounting opening, the catch recess mating with the locking protrusion, and the mounting opening being located below the catch recess and configured to allow the locking protrusion to enter and exit the catch recess.

Abstract: Embodiments of the present disclosure provide a method for lane changing decision for vehicles on expressways considering safety risks in a networked environment, which is applicable to a multi-lane expressway. The method includes collecting a demand for lane change of a target vehicle; collecting a roadway and a lane where the target vehicle is located; collecting intervals between the target vehicle and a front vehicle and a rear vehicle on a lane that is switching into; determining a lane change direction of the vehicle; and executing a lane change operation by the target vehicle. A lane changing decision model provided in the embodiments of the present disclosure helps to improve the efficiency of lane change and the safety of lane change in expressways and provides a support for changing lanes in a multi-lane expressway.

Abstract: The present application provides a lamp with a removable lens, the lamp comprising: a lamp body provided with a mounting portion, a mounting groove being provided in the middle of the mounting portion; a lamp panel arranged on the mounting portion; a lens arranged on a top surface of the lamp panel, a connector being provided in the middle of the lens; a pressing frame, the pressing frame being pivotally arranged on the lamp body such that the pressing frame is capable of being flipped relative to the lamp body, the pressing frame being arranged around the mounting portion, and the pressing frame being in close fit with an upper edge of the lens so as to tightly press the lens on the lamp body; a snap-fit structure arranged between the lamp body and the pressing frame, the snap-fit structure fixing the lamp body and the pressing frame when the pressing frame closely fits with the upper edge of the lens; and a press-type latch structure arranged in the mounting groove, the press-type latch structure having a l

Abstract: Disclosed are solid forms of an activator of soluble guanylate cyclase (sGC). The invention also relates to methods of making these solid forms, pharmaceutical compositions comprising these solid forms, and their use for medical conditions responsive to treatment with an activator of sGC.

Abstract: Disclosed are a phenyl amino sodium propionate derivative, a preparation method therefor and an application thereof. Specifically, disclosed are sodium 3-(4-(2-(9H-carbazole-9-yl)ethoxy)phenyl)-2-((2-(4-(4-(2-sodium forrnate-2-((2-(4-fluorobenzoyl)phenyl)amino)ethyl)phenoxy)benzoyl)phenyl)amino)propionate, a preparation method therefor and the use thereof for quality control of a bulk drug or formulation of Chiglitazar or a derivative thereof. Particularly, the compound can be used as a control substance or standard substance for the detection of impurities/related substances in Chiglitazar or a sodium salt drug thereof.

Abstract: The present invention disclosure also relates to a pharmaceutical composition that ccomprises the compound as an active ingredient.

Abstract: The present invention relates to a hydroxamate compound represented by formula (I), a preparation method therefor, and an application thereof. The present invention also relates to a pharmaceutical composition comprising the compound as an active ingredient and a use of the compound or pharmaceutical composition for treating and/or preventing related diseases mediated by TYK2.

Abstract: A biphenyl compound represented by formula (I), a preparation method therefor and an application thereof. The present invention also relates to a pharmaceutical composition that comprises the compound as an active ingredient. The compound is a novel small molecule immunomodulator having excellent oral absorption features and can be used for treating and/or preventing various immunity-related diseases.

Abstract: A biphenyl compound represented by formula (I), a preparation method therefor and an application thereof. The present invention also relates to a pharmaceutical composition that comprises the compound as an active ingredient. The compound is a novel small molecule immunomodulator having excellent oral absorption features and can be used for treating and/or preventing various immunity-related diseases.

Abstract: The disclosure relates to the technical field of battery charging and swapping, and in particular, to a control method and system for a battery charging and swap station, a medium, an apparatus, and a battery charging and swap station. The disclosure is intended to solve the problem that a battery charging and swap station is prone to false alarm and halt at a low temperature. To this purpose, the battery charging and swap station in the disclosure includes a battery swap apparatus. The battery swap apparatus includes a locking/unlocking mechanism. The locking/unlocking mechanism is configured to be capable of locking and unlocking a battery locking mechanism through rotation of a locking/unlocking head of the locking/unlocking mechanism.

Abstract: A peridynamics-based finite element method (PeriFEM) for an structural damage analysis, comprising the following steps: A1: generating finite elements of a structure, A2: generating peridynamic elements based on the finite elements; A3: calculating a global load vector; A4: calculating a global stiffness matrix; A5: formulating and solving a linear algebra equation about the global node displacement vector; A6: evaluating whether the result satisfies the convergence criteria; if so, go to step A7, if not, return to step A4; A7: increasing the external load successively and loop A3-A7 after that, until the external load exceeds the maximum external load; A8: plotting the results. The implementation of PeriFEM in software includes the following operations: B1: generating the peridynamic elements for inputting into the software; B2: programing the formulation of the element stiffness matrix in step A4 as a subroutine; and B3: setting a method for the updating the subroutine.

Abstract: The disclosure relates to the technical field of safety protection, and in particular, to a safety protection method and system for a battery charging and swap station, a medium, an apparatus, and the battery charging and swap station. The disclosure aims to solve the problem of small coverage of an existing safety protection method. For this purpose, the battery charging and swap station in the disclosure includes a battery swap platform, a battery swap apparatus, position detection devices, and safety scanning devices. The battery swap platform can bear a vehicle with a battery to be swapped. The position detection devices can send an electrical signal when blocked. The safety scanning devices can monitor one of a plurality of preset monitoring regions each time.

Abstract: The present disclosure discloses a method and a system for automatically resuming a call after network handover, and belongs to the field of network calls. In the method of the present disclosure, during a call between a first terminal and a second terminal, when the first terminal is handed over from a first network to a third network, the first terminal first stores call resources, then registers with a server through the third network, constructs a resume request, and sends the resume request to the second terminal via the server, and the second terminal resumes the call with the first terminal according to the resume request. The present disclosure can ensure communication stability after network handover of a communication device, thereby avoiding call interruption caused by the network handover during communication of the communication device.

Abstract: In the present disclosure, a piece is disposed on a glove core of a glove structure, and an edge of the piece is to injected and filled with molding material to have an injection molding assembly thereon. The injection molding assembly at least fills a section gap between the glove core and the edge of the piece. By using the injection molding assembly, the section gap between the glove core and the edge of the piece is masked, and an adhesive effect for bonding the piece is also obtained. Thus, the present disclosure provides positive and reliable means for preventing the edge of the piece from being separated from the glove core, making the glove structure maintain its required function in long term, increasing the quality and the lifetime of the glove structure, and making the glove structure have a curved surface shape to present its three-dimensional shape.

Abstract: A mask, a mask assembly, an exposure machine, a method for testing shadowing effect on a window, and a photolithography method are provided. The mask includes a light transmission area; a functional window provided at a side of the light transmission area; and at least one of a first detection mark and a second detection mark; wherein the first detection mark is flushed with a border of the functional window adjacent to an interior of the mask; and the second detection mark is disposed between the profile of the light transmission area and the functional window.

Abstract: Provided is a quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activity, specifically, provided is a compound of general Formula (I) or pharmaceutically acceptable salt thereof, its pharmaceutical composition, preparation method and use in the manufacture of a medicament for immunomodulating and preventing and/or treating of a disease associated with IDO expression abnormality and/or tryptophan metabolism abnormality. Also provided is use of a combination medication of the quinoline derivative and HDAC inhibitor and its use in the manufacture of an anti-tumor drug.

Abstract: A mask, a mask assembly, an exposure machine, a method for testing shadowing effect on a window, and a photolithography method are provided. The mask includes a light transmission area; a functional window provided at a side of the light transmission area; and at least one of a first detection mark and a second detection mark; wherein the first detection mark is flushed with a border of the functional window adjacent to an interior of the mask; and the second detection mark is disposed between the profile of the light transmission area and the functional window.

Abstract: A glove has a glove core and a glove component. The glove core has a palm portion, a dorsum portion, a side portion of hand and a finger portion; the palm portion and the finger portion are connected to each other via a connection point, the finger piece portion has a first and second bonding portions with a distance therebetween, the finger piece portion is bound to the finger portion via the first bonding portion, and the finger piece portion is bound to the palm portion via the second bonding portion. The connection point, the first bonding portion and the second bonding portion are formed to have a virtual triangle, thus the finger portion and the palm portion have an angle being less than 180 degrees, and that is, the finger portion bends forward the palm portion to make the glove comply with the ergonomic principle.

Abstract: The present invention relates to a formamide compound, a preparation method therefor and an application thereof. The structure of the compound is shown in formula (I), and the definition of each variable in the formula is as provided in the description. The compound is capable of inhibiting the activity of ASK1 kinase. The compound of the present invention may be used in the treatment/prevention of diseases associated with ASK1 kinase, such as inflammatory diseases, metabolic diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, cancers and other diseases.